{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:08:57Z","timestamp":1787162937865,"version":"build-2736575974"},"reference-count":47,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:sec id=\"ab-eoi220036-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>There is a need for validated clinical end points that are reliably able to quantify potential therapeutic effects of future treatments targeting age-related macular degeneration (AMD) before the onset of serious visual impairment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi220036-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To assess the reliability and discriminatory power of 5 simple chart-based visual function (VF) tests as potential measures for clinical trial end points with regulatory and patient-access intention in intermediate AMD (iAMD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi220036-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This international noninterventional study took place at 18 tertiary ophthalmology departments across Europe. Participants were recruited between April 2018 and March 2020 and were identified during routine clinical review. Participants with no AMD and early AMD were recruited from hospital staff, friends, and family of participants with AMD and via referrals from community ophthalmologists and optometrists. The repeatability and discriminatory power of 5 simple chart-based assessments of VF (best-corrected visual acuity [BCVA], low-luminance visual acuity [LLVA], Moorfields Acuity Test [MAT], Pelli-Robson Contrast Sensitivity [CS], and International Reading Speed Test [IReST]) were assessed in a repeated-measures design. VF assessments were performed on day 0 and day 14. Participants with early AMD, iAMD, late AMD, and no AMD were recruited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi220036-7\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Intraclass correlation coefficients (ICCs) and Bland-Altman 95% limits of agreement (LoA) were computed to assess repeatability. Area under the receiver operating characteristic curves (AUCs) determined the discriminatory ability of all measures to classify individuals as having no AMD or iAMD and to differentiate iAMD from its neighboring disease states.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi220036-8\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 301 participants (mean [SD] age, 71 [7] years; 187 female participants [62.1%]) were included in the study. Thirty-four participants (11.3%) had early AMD, 168 (55.8%) had iAMD, 43 (14.3%) had late AMD, and 56 (18.6%) had no AMD. ICCs for all VF measures ranged between 0.88 and 0.96 when all participants were considered, indicating good to excellent repeatability. All measures displayed excellent discrimination between iAMD and late AMD (AUC, 0.92-0.99). Early AMD was indistinguishable from iAMD on all measures (AUC, 0.54-0.64). CS afforded the best discrimination between no AMD and iAMD (AUC, 0.77). Under the same conditions, BCVA, LLVA, and MAT were fair discriminators (AUC, 0.69-0.71), and IReST had poor discrimination (AUC, 0.57-0.61).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-eoi220036-9\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>BCVA, LLVA, MAT, CS, and IReST had adequate repeatability in this multicenter, multiexaminer setting but limited power to discriminate between no AMD and iAMD. The prognostic power of these variables to predict conversion from iAMD to late AMD is being examined in the ongoing longitudinal part of the MACUSTAR study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2022.2113","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T11:33:34Z","timestamp":1655984014000},"page":"780","source":"Crossref","is-referenced-by-count":24,"title":["Repeatability and Discriminatory Power of Chart-Based Visual Function Tests in Individuals With Age-Related Macular Degeneration"],"prefix":"10.1001","volume":"140","author":[{"given":"Hannah M. P.","family":"Dunbar","sequence":"first","affiliation":[{"name":"Department of Visual Neuroscience and Function, University College London Institute of Ophthalmology, London, United Kingdom"},{"name":"Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Behning","sequence":"additional","affiliation":[{"name":"Medical Faculty, Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amina","family":"Abdirahman","sequence":"additional","affiliation":[{"name":"Department of Visual Neuroscience and Function, University College London Institute of Ophthalmology, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany E.","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Optometry and Visual Sciences, School of Health Sciences, City, University London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison M.","family":"Binns","sequence":"additional","affiliation":[{"name":"Department of Optometry and Visual Sciences, School of Health Sciences, City, University London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan H.","family":"Terheyden","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Zakaria","sequence":"additional","affiliation":[{"name":"Translational Medicine, Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Poor","sequence":"additional","affiliation":[{"name":"Ophthalmology Research, Novartis Institute for Biomedical Research, Cambridge, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Finger","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leal","sequence":"additional","affiliation":[{"name":"Bayer AG, Berlin, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank G.","family":"Holz","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schmid","sequence":"additional","affiliation":[{"name":"Medical Faculty, Institute of Medical Biometry, Informatics and Epidemiology, University of Bonn, Bonn, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David P.","family":"Crabb","sequence":"additional","affiliation":[{"name":"Department of Optometry and Visual Sciences, School of Health Sciences, City, University London, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Rubin","sequence":"additional","affiliation":[{"name":"Department of Visual Neuroscience and Function, University College London Institute of Ophthalmology, London, United Kingdom"},{"name":"Moorfields Eye Hospital National Health Service Foundation Trust, London, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich F. O.","family":"Luhmann","sequence":"additional","affiliation":[{"name":"Roche Pharmaceutical Research and Early Development, Translational Medicine Ophthalmology, Roche Innovation Center Basel, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"MACUSTAR Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hansj\u00fcrgen","family":"Agostini","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Bandello","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier, G.","family":"Basile","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Berger","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camiel, J. F.","family":"Boon","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"B\u00f6ttger","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Bouchet","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John, E.","family":"Brazier","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Butt","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Carapezzi","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Carlton","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Carneiro","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Charil","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Coimbra","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Cunha-Vaz","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Dahlke","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"de Sisternes","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Fletcher","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Floyd","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Hogg","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel","family":"Hoyng","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rn","family":"Kr\u00e4tzschmar","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"K\u00fchlewein","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Larsen","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Luning","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cec\u00edlia, V.","family":"Martinho","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz, A.","family":"Mel\u00edcio","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saddek","family":"Mohand-Sa\u00efd","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrina","family":"Nunes","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacristina","family":"Parravano","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Pauleikhoff","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Pfau","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne, G.","family":"Pondorfer","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Priglinger","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Rowen","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A","family":"Sahel","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sanches Fernandes","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara I.","family":"S\u00e1nchez","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Sa\u00dfmannshausen","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Schmitz-Valckenberg","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Schrinner-Fenske","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufino","family":"Silva","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Skelly","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Souied","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Staurenghi","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"St\u00f6hr","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Tavares","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deanna, J.","family":"Taylor","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Thiele","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adnan","family":"Tufail","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludmila","family":"Wintergerst","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wojek","sequence":"additional","affiliation":[{"name":"for the MACUSTAR Consortium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"1","key":"eoi220036r1","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2165\/00019053-200826010-00006","article-title":"Economic burden of bilateral neovascular age-related macular degeneration: multi-country observational study.","volume":"26","author":"Cruess","year":"2008","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"eoi220036r2","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1136\/bjo.2007.116939","article-title":"Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: results from the UK cohort of a five-country cross-sectional study.","volume":"91","author":"Lotery","year":"2007","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"eoi220036r3","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1167\/iovs.07-1132","article-title":"Report from the NEI\/FDA ophthalmic clinical trial design and endpoints symposium.","volume":"49","author":"Csaky","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"14","key":"eoi220036r4","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1056\/NEJMoa054481","article-title":"Ranibizumab for neovascular age-related macular degeneration.","volume":"355","author":"Rosenfeld","year":"2006","journal-title":"N Engl J Med"},{"issue":"14","key":"eoi220036r5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJMoa062655","article-title":"Ranibizumab versus verteporfin for neovascular age-related macular degeneration.","volume":"355","author":"Brown","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"eoi220036r6","doi-asserted-by":"publisher","first-page":"e43","DOI":"10.1016\/j.ddstr.2012.11.002","article-title":"Visual function endpoints to enable dry AMD clinical trials.","volume":"10","author":"Lesmes","year":"2013","journal-title":"Drug Discov Today Ther Strateg"},{"issue":"1","key":"eoi220036r7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12886-020-01467-0","article-title":"Functionally validated imaging endpoints in the Alabama study on early age-related macular degeneration 2 (ALSTAR2): design and methods.","volume":"20","author":"Curcio","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"2","key":"eoi220036r8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1159\/000491402","article-title":"MACUSTAR: development and clinical validation of functional, structural, and patient-reported endpoints in intermediate age-related macular degeneration.","volume":"241","author":"Finger","year":"2019","journal-title":"Ophthalmologica"},{"issue":"4","key":"eoi220036r9","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.ophtha.2015.12.009","article-title":"The natural history of the progression of atrophy secondary to Stargardt disease (ProgStar) studies: design and baseline characteristics: ProgStar report no. 1.","volume":"123","author":"Strauss","year":"2016","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi220036r10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/ceo.13458","article-title":"Progression of retinitis pigmentosa on multimodal imaging: the PREP-1 study.","volume":"47","author":"Iftikhar","year":"2019","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"eoi220036r11","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1159\/000515148","article-title":"Clinical perspectives and trends: microperimetry as a trial endpoint in retinal disease.","volume":"244","author":"Yang","year":"2021","journal-title":"Ophthalmologica"},{"issue":"4","key":"eoi220036r13","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration.","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi220036r14","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1186\/s13063-020-04595-6","article-title":"Clinical study protocol for a low-interventional study in intermediate age-related macular degeneration developing novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention-MACUSTAR.","volume":"21","author":"Terheyden","year":"2020","journal-title":"Trials"},{"issue":"9","key":"eoi220036r15","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ophtha.2008.03.009","article-title":"Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.","volume":"115","author":"Sunness","year":"2008","journal-title":"Ophthalmology"},{"issue":"10","key":"eoi220036r16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1136\/bjophthalmol-2015-307375","article-title":"Visual acuity loss in patients with age-related macular degeneration measured using a novel high-pass letter chart.","volume":"100","author":"Shah","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"eoi220036r17","first-page":"187","article-title":"The design of a new letter chart for measuring contrast sensitivity.","volume":"2","author":"Pelli","year":"1988","journal-title":"Clin Vis Sci"},{"issue":"4","key":"eoi220036r18","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1136\/bjo.2005.087379","article-title":"New standardised texts for assessing reading performance in four European languages.","volume":"90","author":"Hahn","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"eoi220036r19","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1167\/iovs.11-8284","article-title":"Standardized assessment of reading performance: the New International Reading Speed Texts IReST.","volume":"53","author":"Trauzettel-Klosinski","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi220036r20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231748","article-title":"Detecting vision loss in intermediate age-related macular degeneration: A comparison of visual function tests.","volume":"15","author":"Pondorfer","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"eoi220036r21","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1167\/iovs.61.3.55","article-title":"Association of visual function measures with drusen volume in early stages of age-related macular degeneration.","volume":"61","author":"Pondorfer","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"eoi220036r22","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1016\/j.ophtha.2014.02.005","article-title":"Low-luminance visual acuity and microperimetry in age-related macular degeneration.","volume":"121","author":"Wu","year":"2014","journal-title":"Ophthalmology"},{"key":"eoi220036r23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ajo.2018.02.012","article-title":"Visual function metrics in early and intermediate dry age-related macular degeneration for use as clinical trial endpoints.","volume":"189","author":"Cocce","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"eoi220036r24","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s12886-020-01683-8","article-title":"An exploratory study to evaluate visual function endpoints in non-advanced age-related macular degeneration.","volume":"20","author":"Narayanan","year":"2020","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"eoi220036r25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s12874-021-01243-8","article-title":"Challenges, facilitators and barriers to screening study participants in early disease stages-experience from the MACUSTAR study.","volume":"21","author":"Terheyden","year":"2021","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"eoi220036r26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1167\/tvst.11.3.27","article-title":"Intersession repeatability of structural biomarkers in early and intermediate age-related macular degeneration: a MACUSTAR study report.","volume":"11","author":"Sa\u00dfmannshausen","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"8476","key":"eoi220036r27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement.","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"issue":"5","key":"eoi220036r28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/IAE.0000000000001002","article-title":"Visual function measures in early and intermediate age-related macular degeneration.","volume":"36","author":"Chandramohan","year":"2016","journal-title":"Retina"},{"issue":"12","key":"eoi220036r29","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/00006324-200012000-00012","article-title":"The relation between visual acuity and other spatial vision measures.","volume":"77","author":"Haegerstrom-Portnoy","year":"2000","journal-title":"Optom Vis Sci"},{"issue":"11","key":"eoi220036r30","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1097\/01.opx.0000187863.12609.7b","article-title":"Reliability and consistency of visual acuity and contrast sensitivity measures in advanced eye disease.","volume":"82","author":"Kiser","year":"2005","journal-title":"Optom Vis Sci"},{"issue":"10","key":"eoi220036r32","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1167\/iovs.08-1935","article-title":"Intersession repeatability of visual acuity scores in age-related macular degeneration.","volume":"49","author":"Patel","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"eoi220036r33","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1167\/iovs.08-2407","article-title":"Intersession repeatability of contrast sensitivity scores in age-related macular degeneration.","volume":"50","author":"Patel","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi220036r34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1167\/iovs.03-1320","article-title":"The effect of optical defocus on the test-retest variability of visual acuity measurements.","volume":"45","author":"Rosser","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi220036r35","first-page":"120","article-title":"On the statistical reliability of letter-chart visual acuity measurements.","volume":"34","author":"Arditi","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi220036r36","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1475-1313.1988.tb01176.x","article-title":"The use of accurate visual acuity measurements in clinical anti-cataract formulation trials.","volume":"8","author":"Elliott","year":"1988","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"eoi220036r37","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/opo.12775","article-title":"Low luminance visual acuity as a clinical measure and clinical trial outcome measure: a scoping review.","volume":"41","author":"Wood","year":"2021","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"eoi220036r38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/OPX.0000000000000584","article-title":"Determinants and standardization of mesopic visual acuity.","volume":"92","author":"Lin","year":"2015","journal-title":"Optom Vis Sci"},{"issue":"3","key":"eoi220036r39","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1167\/iovs.13-13340","article-title":"Effect of scoring and termination rules on test-retest variability of a novel high-pass letter acuity chart.","volume":"55","author":"Shah","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi220036r40","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1475-1313.1990.tb01100.x","article-title":"The reliability of the Pelli-Robson contrast sensitivity chart.","volume":"10","author":"Elliott","year":"1990","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"eoi220036r41","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00417-013-2421-5","article-title":"Repeatability of visual function measures in age-related macular degeneration.","volume":"252","author":"Aslam","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"eoi220036r42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.visres.2013.02.015","article-title":"Measuring reading performance.","volume":"90","author":"Rubin","year":"2013","journal-title":"Vision Res"},{"issue":"12","key":"eoi220036r43","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/00006324-198912000-00008","article-title":"Psychophysics of reading. VIII. the Minnesota low-vision reading test.","volume":"66","author":"Legge","year":"1989","journal-title":"Optom Vis Sci"},{"issue":"8","key":"eoi220036r44","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.oret.2019.03.010","article-title":"Longitudinal study of visual function in dry age-related macular degeneration at 12 months.","volume":"3","author":"Hsu","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"eoi220036r45","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3.","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi220036r46","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4.","volume":"127","author":"Guymer","year":"2020","journal-title":"Ophthalmology"},{"key":"eoi220036r47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2021.01.017","article-title":"Normal- and Low-Luminance Automated Quantitative Contrast Sensitivity Assessment in Eyes With Age-Related Macular Degeneration.","volume":"226","author":"Ou","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"eoi220036r12","volume-title":"Clinical Trials: design, conduct and analysis","author":"Meinert","year":"2012"},{"key":"eoi220036r31","first-page":"246","volume-title":"Vision Science and Its Applications","author":"Woods","year":"1995"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2793766\/jamaophthalmology_dunbar_2022_oi_220036_1660767198.64512.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T12:09:58Z","timestamp":1700741398000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2793766"}},"subtitle":["A MACUSTAR Study Report"],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2022.2113","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}